Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Response to Covid-19

1 Apr 2020 07:00

RNS Number : 3217I
Royal Bank of Scotland Group PLC
01 April 2020
 

31 March 2020

The Royal Bank of Scotland Group plc

Response to Covid-19

In order to serve the needs of businesses and households through the unprecedented situation presented by Covid-19, the Royal Bank of Scotland Group plc ("RBS") Board of Directors ("Board") has decided to undertake no quarterly or interim dividend payments, accrual of dividends or share buybacks and defer decisions on any future shareholder distributions until the end of 2020.

In response to a formal request from the Prudential Regulatory Authority, the Board has also decided to cancel the final ordinary and special dividend payments in relation to the 2019 financial year ("2019 final dividends") and not submit them for approval to the RBS AGM to be held on 29 April 2020.

RBS continues to maintain its robust capital and liquidity position and enters this period with more than sufficient capital to accommodate the combined simultaneous impact of severe UK and global recessions and a financial markets shock as demonstrated through our performance in recent Bank of England stress tests.

As a result of this Board action, the 2019 final dividends and an associated dividend-linked contribution to the main RBS UK pension scheme(1), are cancelled. These were reflected in the 31 December 2019 CET1 capital as foreseeable deductions, in particular:

· Ordinary dividend of 3p per share totalling £363m and equating to 20 bps of Q4'19 CET1;

· Special dividend of 5p per share totalling £605m and equating to 34 bps of Q4'19 CET1; and

· Dividend linked contribution of £500m pre-tax, £365m post-tax, and equating to 20 bps of Q4'19 CET1.

This Board action reduces the RBS CET1 capital deductions by £1,333m, equating to an improvement from the FY19 published 16.2% CET1 ratio of 74 bps.

For completeness, this has no impact on the payment of interest on outstanding preference shares or Alternative Tier 1 instruments ("AT1") issued by RBS and its subsidiaries.

The Board remains committed to capital returns, will continue to review the situation and will look to resume distributions to ordinary shareholders in due course.

RBS Chief Executive Alison Rose said:

"RBS has a robust capital and liquidity position and we are focused on ensuring we support our customers and help them to navigate the immediate and longer-term challenges they are facing as a result of Covid-19.

"As we continue to build a purpose led bank we are committed to balancing the needs of all our stakeholders. Helping people, families and businesses who need our support is the right thing to do at this time of significant uncertainty.

"The Board remains committed to capital returns, will continue to review the situation and will look to resume distributions to ordinary shareholders in due course."

(1) - Under the terms of the agreement with its main UK pension scheme trustee in April 2018, RBS is committed to make contributions to that scheme from 2020 at a level matching shareholder distributions made during each year up to an annual maximum of £500 million and a cumulative total of £1.5 billion.

For further information, please contact:

Investor Relations

Alexander Holcroft

Head of Investor Relations

+44 (0) 207 672 1758

 

RBS Media Relations

+44 (0) 131 523 4205

 

Forward-looking statements 

This announcement contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, such as statements that include, without limitation, the words 'expect', 'estimate', 'project', 'anticipate', 'commit', 'believe', 'should', 'intend', 'plan', 'could', 'probability', 'risk', 'Value-at-Risk (VaR)', 'target', 'goal', 'objective', 'may', 'endeavour', 'outlook', 'optimistic', 'prospects' and similar expressions or variations on these expressions. These statements concern or may affect future matters, such as RBS's future economic results, business plans and current strategies.  In particular, this document may include forward-looking statements relating to RBS in respect of, but not limited to: its regulatory capital position and related requirements, its financial position, profitability and financial performance (including financial, capital and operational targets), its access to adequate sources of liquidity and funding, increasing competition from new incumbents and  disruptive technologies, its exposure to third party risks, its ongoing compliance with the UK ring-fencing regime and ensuring operational continuity in resolution, its impairment losses and credit exposures under certain specified scenarios, substantial regulation and oversight, ongoing legal, regulatory and governmental actions and investigations, LIBOR, EURIBOR and other benchmark reform and RBS's exposure to economic and political risks (including with respect to Brexit and climate change), operational risk, conduct risk, cyber and IT risk, key person risk and credit rating risk.  Forward-looking statements are subject to a number of risks and uncertainties that might cause actual results and performance to differ materially from any expected future results or performance expressed or implied by the forward-looking statements. Factors that could cause or contribute to differences in current expectations include, but are not limited to, the final number of PPI claims and their amounts, legislative, political, fiscal and regulatory developments, accounting standards, competitive conditions, technological developments, interest and exchange rate fluctuations and general economic conditions. These and other factors, risks and uncertainties that may impact any forward-looking statement or RBS's actual results are discussed in RBS's UK 2018 Annual Report and Accounts (ARA), RBS's Interim Results for H1 2019 and materials filed with, or furnished to, the US Securities and Exchange Commission, including, but not limited to, RBS's most recent Annual Report on Form 20-F and Reports on Form 6-K. The forward-looking statements contained in this document speak only as of the date of this document and RBS does not assume or undertake any obligation or responsibility to update any of the forward-looking statements contained in this document, whether as a result of new information, future events or otherwise, except to the extent legally required.

MAR - Inside Information

This announcement contains information that qualified or may have qualified as inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 (MAR).  For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, this announcement is made by Alexander Holcroft, Head of Investor Relations for The Royal Bank of Scotland Group.

 

Legal Entity Identifier  

The Royal Bank of Scotland Group plc

2138005O9XJIJN4JPN90

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDWPURUWUPUPGG
Date   Source Headline
20th Sep 20197:00 amRNSAppointment of CEO
12th Sep 20192:29 pmRNSForm 8.3 - Accesso Technology Group plc
9th Sep 20198:30 amRNSBarclays Global Financial Services Conference
5th Sep 20192:10 pmRNSPublication of Suppl.Prospcts
4th Sep 20197:00 amRNSUpdate on Charges Related to PPI
3rd Sep 201912:49 pmRNSForm 8.3 - Accesso Technology Group plc
30th Aug 20193:03 pmRNSTotal Voting Rights
29th Aug 20195:16 pmRNSDirector/PDMR Shareholding
29th Aug 20193:13 pmRNSDividend Declaration
14th Aug 20192:53 pmRNSDirector/PDMR Shareholding
12th Aug 20192:58 pmRNSForm 8.3 - Accesso Technology Group plc
5th Aug 20197:15 amRNSDirector Declaration
5th Aug 20197:00 amRNSAppointment of Non-Executive Director
2nd Aug 20192:43 pmRNSPublication of a Prospectus
2nd Aug 20197:31 amRNSNatWest Markets N.V. Interim Results 2019
2nd Aug 20197:00 amRNSInterim Results 2019 - Part 2 of 2
2nd Aug 20197:00 amRNSInterim Results 2019 - Part 1 of 2
31st Jul 20195:41 pmRNSDirector/PDMR Shareholding
31st Jul 201912:43 pmRNSTotal Voting Rights
25th Jul 20193:07 pmRNSForm 8.3 - Accesso Technology Group PLC
19th Jul 20197:00 amRNSRoss McEwan announced CEO National Australia Bank
16th Jul 201910:22 amRNSDirector Declaration
3rd Jul 20191:58 pmRNSForm 8 (DD) - Premier Technical Services Group plc
1st Jul 20191:54 pmRNSDirector/PDMR Shareholding
28th Jun 20192:45 pmRNSDividend Declaration
28th Jun 20191:19 pmRNSTotal Voting Rights
24th Jun 20198:00 amRNSRBS Investor Seminar : Technology & Innovation
20th Jun 20192:33 pmRNSTakeover Panel PremierTechnical Services Group plc
18th Jun 20195:09 pmRNSPublication of Suppl.Prospcts
17th Jun 20197:00 amRNSImpact of Alawwal bank / Saudi British Bank merger
11th Jun 20193:02 pmRNSDirector/PDMR Shareholding
3rd Jun 20193:33 pmRNSConfirmation re stated post-offer intentions
31st May 20195:06 pmRNSDividend Declaration
31st May 20193:04 pmRNSTotal Voting Rights
31st May 201912:39 pmRNSDirector/PDMR Shareholding
20th May 20196:04 pmRNSForm 8.3 - WYG PLC
20th May 201910:37 amRNSPublication of Suppl.Prospcts
16th May 20194:11 pmRNSRBS Group welcomes credit ratings action by S&P
16th May 201911:40 amRNSAcknowledgment of two settlements on FX trading
10th May 20193:12 pmRNSDirector/PDMR Shareholding
3rd May 201912:10 pmRNSRBSG pricing of US$1.25bn of Senior Notes
2nd May 201910:25 amRNSDirector/PDMR Shareholding
30th Apr 20193:24 pmRNSTotal Voting Rights
29th Apr 201911:07 amRNSPublication of Suppl.Prospcts
26th Apr 20197:00 amRNSQ1 Interim Management Statement
25th Apr 20196:03 pmRNSResult of AGM
25th Apr 20192:00 pmRNSAGM Statement
25th Apr 20197:00 amRNSDirectorate Change
24th Apr 20193:03 pmRNSDividend Declaration
23rd Apr 201912:46 pmRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.